1. Home
  2. SRTS vs ONMD Comparison

SRTS vs ONMD Comparison

Compare SRTS & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$3.19

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$0.91

Market Cap

56.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTS
ONMD
Founded
2010
2006
Country
United States
United States
Employees
60
23
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.5M
56.0M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
SRTS
ONMD
Price
$3.19
$0.91
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
72.2K
857.0K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,482,000.00
N/A
Revenue This Year
$2.00
N/A
Revenue Next Year
$34.23
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.82
$0.31
52 Week High
$5.92
$4.22

Technical Indicators

Market Signals
Indicator
SRTS
ONMD
Relative Strength Index (RSI) 34.42 49.91
Support Level $3.03 $0.92
Resistance Level $3.53 $0.97
Average True Range (ATR) 0.26 0.08
MACD -0.04 -0.02
Stochastic Oscillator 23.97 48.84

Price Performance

Historical Comparison
SRTS
ONMD

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: